Gold ETFs hit record inflows of nearly $40B in 1H20
ETF.com Managing Editor Cinthia Murphy joins Yahoo Finance's Kristin Myers to break down her outlook on gold ETFs, as the precious metal jumps above $1,800.
ETF.com Managing Editor Cinthia Murphy joins Yahoo Finance's Kristin Myers to break down her outlook on gold ETFs, as the precious metal jumps above $1,800.
There’s been a lot of talk recently about this year’s bull market, both on its own merits and in comparison to last year. But somewhat less attention has been paid to it as part of a larger trend overall – a secular bull market that began in 2013 and has seen the S&P 500 reach recent record highs. Long-term trends are good for the market generally, but what the average retail investor really wants is a solid return in the here-and-now. There are several routes to accomplish this, and one of the
Wednesday, the FDA approved Akebia Therapeutics Inc (NASDAQ:AKBA) Vafseo (vadadustat) tablets for anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months. Vafseo is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that activates the physiologic response to hypoxia to stimulate endogenous production of erythropoietin to manage anemia. Vafseo is now approved in 37 countries. The approval of Vafseo is based on e
If you're taking a required minimum distribution from an IRA, 401(k) or other tax-deferred account and don't need the money to cover living expenses, where should you stash that unneeded cash? Investors now need to start taking RMDs at age 73 or, if they were born after 1960, at age 75. Depending on the balances of […] The post Can I Use My RMDs to Transfer Money Into My Roth IRA? appeared first on SmartReads by SmartAsset.
Canoo (GOEV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
An analyst downgraded Palantir stock on views the data analytics software maker's valuation is inflated amid investor buzz over generative artificial intelligence.
The once-booming EV market in China is experiencing a slowdown due to economic challenges and reduced government subsidies, prompting a shift in strategy among local and international automakers.
Trump Media reported revenue of $3.4 million and a loss of $49 million during the first nine months of 2023, and received a $300 million cash infusion as part of its listing via a merger with a special-purpose acquisition vehicle, or SPAC. The company’s price-to-sales valuation far outstrips even the buzziest of its social-media peers such as Reddit and Facebook and Instagram parent Meta Platforms So far, no Wall Street analysts have put a rating or target price on Trump Media stock, according to FactSet.
The soon-to-be spun-off power generation business of General Electric—GE Vernova—is getting more expensive, while the remaining business, GE Aerospace, is getting cheaper. Shares were up 1.5% at $133.15 in midday trading on Thursday. GE shareholders get one share of Vernova for every four GE shares held.
In a post on X, formerly Twitter, Florida Governor Ron DeSantis announced that he signed legislation “to end the squatters scam & protect homeowners.” Governor Ron DeSantis Signs Legislation to End the Squatters Scam & Protect Homeowners https://t.co/MjqOKiAHPZ — Ron DeSantis (@GovRonDeSantis) March 27, 2024 "We are putting an end to the squatters scam in Florida," DeSantis said in a release on his website. "While other states are siding with the squatters, we are protecting property owners and
Owning shares of an industry-leading enterprise with numerous positive attributes seems like a no-brainer decision.
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.
The age when retired workers claim Social Security benefits has a substantial impact on their payout.
Akebia (AKBA) gains during premarket hours on Mar 28 as its key product Vafseo (vadadustat) tablets receive FDA's approval for the treatment of anemia due to chronic kidney disease.
Investors should not ignore the rise of AI despite the hype around certain companies.
MicroStrategy stock is falling after a short seller said Thursday the company is overvalued. The hedge fund Kerrisdale Capital said it is long Bitcoin and short MicroStrategy, whose shares have rallied largely due to the soaring value of cryptocurrency owned by the company. “Our thesis is not predicated on a bearish view of bitcoin or MicroStrategy, but rather a belief that the relationship between the two has grown distorted,” wrote the hedge fund, who said the stock trades at a premium of more than two times the value of its bitcoin.
The conversational artificial intelligence (AI) specialist has been a hot commodity in recent months, but there are less risky ways to profit from this secular tailwind.
These energy stocks have been on fire this year.
Though Chipotle's stock has been sizzling, two industry-leading businesses that appear primed for stock splits of their own look like smarter buys.
The market can't ignore this food giant's ongoing turnaround efforts forever.